Sandoz CEO Richard Saynor has added to criticism over the Federal Circuit’s precedential ruling that a generic manufacturer’s marketing of a product under a skinny label does not prevent infringement of patents for carved out uses, insisting it contradicts “provisions that were originally put in place.”
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?